National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting, 28548 [05-9865]
Download as PDF
<![CDATA[
28548
Federal Register / Vol. 70, No. 95 / Wednesday, May 18, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel to review
Small Research Grants (R03s).
Date: May 17, 2005.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817
(Telephone conference call).
Contact Person: Erich H. Brown, MS, PhD.,
Scientific Review Administrator, National
Institute of Arthritis, Musculoskeletal & Skin
Diseases, National Institutes of Health, 6701
Democracy Blvd, Room 824, MSC 4872,
Bethesda, MD 20892–4872, (301) 435–0815,
browneri@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: May 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9862 Filed 5–17–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate jul<14>2003
16:59 May 17, 2005
Jkt 205001
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Pilot &
Feasibility for Osteoporosis.
Date: June 6, 2005.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Double Tree Hotel, Executive
Meeting Center, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Yan Z. Wang, MD, PhD,
Scientific Review Administrator, National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Blvd, Suite
820, Bethesda, MD 20892, (301) 594–4957.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: May 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–9865 Filed 5–17–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders C.
Date: June 14–15, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Washington, DC, 1400 M
Street, NW., Washington, DC 20005.
Contact Person: Andrea Sawczuk, DDS,
PhD., Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research, NINDS/NIH/DHHS,
6001 Executive Boulevard, Room #3208,
Bethesda, MD 20892, 301–496–0660,
sawczuka@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders A.
Date: June 23–24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
application.
Place: Wyndham City Center Hotel, 1143
New Hampshire Ave., NW., Washington, DC
20037.
Contact Person: Richard D. Crosland, PhD.,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd, Suite 3208,
MSC 9529, Bethesda, MD 20892–9529, 301–
496–9223.
Name of Committee: Training Grant and
Career Development Review Committee.
Date: June 23–24, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Jurys Washington Hotel, 1500 New
Hampshire Ave., NW., Washington, DC
20036.
Contact Person: Raul A. Saavedra, PhD.,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, NSC; 6001
Executive Blvd., Ste. 3208, Bethesda, MD
20892–9529, 301–496–9223,
saavedrr@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders B.
Date: June 23–24, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: W. Ernest Lyons, PhD.,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529, 301–496–4056.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders K, Neurological Diseases.
Date: June 23–24, 2005.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 70, Number 95 (Wednesday, May 18, 2005)]
[Notices]
[Page 28548]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9865]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and
Musculoskeletal and Skin Diseases Special Emphasis Panel, Pilot &
Feasibility for Osteoporosis.
Date: June 6, 2005.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: Double Tree Hotel, Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Yan Z. Wang, MD, PhD, Scientific Review
Administrator, National Institute of Arthritis and Musculoskeletal
and Skin Diseases, 6701 Democracy Blvd, Suite 820, Bethesda, MD
20892, (301) 594-4957.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: May 11, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-9865 Filed 5-17-05; 8:45 am]
BILLING CODE 4140-01-M
